0001493152-26-023677.txt : 20260515 0001493152-26-023677.hdr.sgml : 20260515 20260515154611 ACCESSION NUMBER: 0001493152-26-023677 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260515 DATE AS OF CHANGE: 20260515 EFFECTIVENESS DATE: 20260515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Majesty Therapeutics, Inc. CENTRAL INDEX KEY: 0002135155 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-584279 FILM NUMBER: 26986413 BUSINESS ADDRESS: STREET 1: 41 SENECA ROAD CITY: SEA RANCH LAKES STATE: FL ZIP: 33308 BUSINESS PHONE: (561) 706-3250 MAIL ADDRESS: STREET 1: 41 SENECA ROAD CITY: SEA RANCH LAKES STATE: FL ZIP: 33308 D 1 primary_doc.xml X0708 D LIVE 0002135155 Majesty Therapeutics, Inc. 41 SENECA ROAD SEA RANCH LAKES FL FLORIDA 33308 561-706-3250 DELAWARE None None Corporation true 2024 Shawn Titcomb 41 Seneca Road Sea Ranch Lakes FL FLORIDA 33308 Executive Officer Director Chief Executive Officer Adrian Hepner 41 Seneca Road Sea Ranch Lakes FL FLORIDA 33308 Executive Officer Acting Chief Medical Officer Ankit Bhargava 41 Seneca Road Sea Ranch Lakes FL FLORIDA 33308 Executive Officer Acting Chief Scientific Officer Biotechnology Decline to Disclose 06b false 2026-05-01 true true true SAFE false 0 Wilmington Capital Securities 000133839 None None 666 Old Country Road Suite 505 Garden City NY NEW YORK 11530 All States false 5000000 100000 4900000 false 3 325000 true 0 The amount payable is dependent upon the amount sold and the composition of the investors. 0 true Proceeds of the offering will be used for research and development, trial design and regulatory filings, manufacturing, working capital and general corporate purposes and potentially for the acquisition of, or investment in, complementary businesses false Majesty Therapeutics, Inc. /s/ Shawn Titcomb Shawn Titcomb Chief Executive Officer 2026-05-15